AN ACT relating to ibogaine research in the Commonwealth.

Create new sections of KRS Chapter 218A to define terms; establish the ibogaine research and intellectual property fund to be administered by the Department of Agriculture for the purpose of allowing the department to enter a public-private partnership with a drug developer to conduct a clinical drug development trial or trials related to the use of ibogaine for the treatment of opioid use disorder, co-occurring substance use disorder, or any other neurological or mental health…

Agriculture Appropriations Budget and Financial Administration Drugs and Medicines Effective Dates, Emergency Funds Opioids Public Health State Agencies

In effect since April 14, 2026

This act carries an emergency clause, so it took effect as soon as it became law instead of waiting the usual 90 days after the session adjourned (Ky. Constitution § 55).

Read the full text Kentucky Legislature LegiScan

AI-generated. Always verify with primary sources

Plain-language summary

Beta

This bill sets up a state fund to support clinical research trials on ibogaine, a substance being studied as a potential treatment for opioid use disorder and other mental health or neurological conditions. It allows the Department of Agriculture to partner with a private drug developer to conduct that research. The bill directs $21 million from the existing opioid abatement trust fund to support this effort over two fiscal years. Who it may affect: Kentuckians living with opioid use disorder or other substance use and mental health conditions, as well as researchers and drug developers working in this field.

Open official bill text (PDF)·Report a problem with the summary